University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0022) is a clinical research site located in Chicago, Illinois, United States 60612.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0022) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Metastatic Non-small Cell Lung Cancer.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0022) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0022) has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Non-small Cell Lung Cancer.
University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0022) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.